7 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 6 with minor changes only.
Primary completion pushed from Dec 2026 to Aug 2027
Shandong Suncadia Medicine Co., Ltd.Phase 3 NCT07024173 Registry history of NCT07024173 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Shandong Suncadia Medicine Co., Ltd.Phase 2 NCT07470983 Registry history of NCT07470983 on ClinicalTrials.gov (opens the registry)
Trial completed
Shandong Suncadia Medicine Co., Ltd.Phase 1 NCT07608705 Registry history of NCT07608705 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Oct 2026 to Aug 4, 2026
Shandong Suncadia Medicine Co., Ltd.Phase 1 NCT07322016 Registry history of NCT07322016 on ClinicalTrials.gov (opens the registry)
Trial completed
Shandong Suncadia Medicine Co., Ltd.Phase 1 NCT07351968 Registry history of NCT07351968 on ClinicalTrials.gov (opens the registry)
Completed without a posted recruiting period
Shandong Suncadia Medicine Co., Ltd.Phase 1 NCT07639905 Registry history of NCT07639905 on ClinicalTrials.gov (opens the registry)
Trial completed
Shandong Suncadia Medicine Co., Ltd.Phase 1 NCT07479641 Registry history of NCT07479641 on ClinicalTrials.gov (opens the registry)
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-15 | NCT07876596 A Drug-Drug Interaction Study of Rifampicin and Oral HRS-8080 | Phase 1 | Not Yet Recruiting |
| Phase 1 | 10 | |
| Phase 1/2 | 5 | |
| Phase 2 | 12 | |
| Phase 2/3 | 2 | |
| Phase 3 | 8 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07024173 | A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and… | Locally Advanced Breast Cancer | Recruiting | 2026-10-02 |
| NCT07528027 | Phase III Study of HRS-7535 for Hypertension With Overweight or Obesity | Hypertension With Overweight or Obesity | Recruiting | 2026-09-24 |
| NCT07419828 | A Phase III Clinical Study on the Efficacy and Safety of HRS-1780 in the Treatment of… | Chronic Kidney Disease | Recruiting | 2026-07-17 |
| NCT07354022 | A Study to Evluate Efficacy and Safety of HRS-8080 Combined With Dalpiciclib in Patients… | Locally Advanced or Metastatic Breast Cancer | Recruiting | 2026-06-02 |
| NCT07349069 | A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With… | Breast Cancer | Recruiting | 2026-05-22 |
| NCT07021976 | A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy | Obstructive Hypertrophic Cardiomyopathy | Active, Not Recruiting | 2026-08-24 |
| NCT07625774 | Renal Efficacy and Safety of the Novel Oral Small-Molecule GLP-1RA HRS-7535 Evaluated in… | Chronic Kidney Disease | Not Yet Recruiting | 2026-06-04 |
| NCT07601048 | A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who… | KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment | Not Yet Recruiting | 2026-05-22 |
| Phase 2/3 | ||||
| NCT07185594 | A Phase Ⅱ/Ⅲ Study of HRS-2129 for Postsurgical Pain Management in Abdominal Surgery | Postoperative Analgesia | Recruiting | 2025-11-17 |
| NCT07708441 | A Trial of HRS-1780 in Participants With Uncontrolled Hypertension or Resistant… | Uncontrolled or Resistant Hypertension | Not Yet Recruiting | 2026-09-01 |
| Phase 2 | ||||
| NCT07706777 | Clinical Study of HRS-2129 for Acute Gouty Arthritis | Acute Gouty Arthritis | Recruiting | 2026-09-03 |
| NCT07589569 | An Open-label, Multicenter, Phase II Clinical Study to Evaluate HRS-7058 in Patients With… | Pancreatic Cancer | Recruiting | 2026-06-11 |
| NCT07229950 | A Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of… | Adult Patients With Moderately to Severely Active Ulcerative Colitis | Recruiting | 2026-06-02 |
| NCT07269717 | A Phase II Clinical Trial of HRS-1893 in the Treatment of Heart Failure With Preserved… | Heart Failure With Preserved Ejection Fraction | Recruiting | 2026-05-11 |
| NCT07032077 | A Clinical Trial of HRS-7058 Combined Anti-tumor Drugs in Subjects With Solid Tumors | Solid Tumors | Recruiting | 2026-03-20 |
| NCT06915142 | A Phase II Clinical Study of HRS-7058 in Combination With Antitumor Drugs in Patients… | Advanced Malignant Tumour | Recruiting | 2026-01-26 |
| NCT06820099 | Study on the Efficacy and Safety of HRS-7535 in Patients With Mild Decrease in Ejection… | Adults With Heart Failure, Mild Decrease in Ejection Fraction/Preserved Ejection Fraction, and Obesity | Recruiting | 2025-12-29 |
| NCT07229937 | A Phase II Study To Evaluate the Efficacy And Safety Of HRS-1301 In Participants With… | Hyperlipidemia | Recruiting | 2025-12-12 |
| NCT07021963 | A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic… | Hypertrophic Cardiomyopathy | Recruiting | 2025-09-10 |
| NCT07470983 | A Phase II Clinical Study on the Efficacy and Safety of HRS-1780 in Participants With… | Primary Aldosteronism | Active, Not Recruiting | 2026-10-13 |
| NCT07767513 | Study of Oral HRS-5346 in Adult Patients With Elevated Lipoprotein(a) and High Risk of… | Lipoprotein Disorder | Not Yet Recruiting | 2026-08-17 |
| NCT06516068 | A Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy | Obstructive Hypertrophic Cardiomyopathy | Active, Not Recruiting | 2025-07-16 |
| Phase 1/2 | ||||
| NCT06922357 | A Phase I/II of HRS-6719 in Patients With Advanced/Metastatic Solid Tumors | Advanced/Metastatic Solid Tumors | Recruiting | 2026-05-28 |
| NCT07389733 | A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or… | Advanced Unresectable or Metastatic Breast Cancer of Adults | Recruiting | 2026-04-03 |
| NCT06679036 | A Trial of HRS-2189 in Combination With Fluvastatin±HRS-6209, or HRS-8080±HRS-6209, or… | Advanced Unresectable or Metastatic Breast Cancer | Recruiting | 2026-03-02 |
Breast Cancer (8) · Heart Disease (7) · Chronic Kidney Disease (3) · Heart Failure (3) · Obesity (3) · Hypertension (2) · Lung Cancer (1) · Non-Small Cell Lung Cancer (NSCLC) (1) · Pancreatic Cancer (1) · Ulcerative Colitis (1)